Depression and anxiety severity scores increased among U.S. adults from August to December 2020, followed by decrease through mid-2021
Increases in Major Depressive Disorder, Anxiety Reported Due to COVID-19
Increase of 27.6 percent seen in cases of major depressive disorder globally; 25.6 percent increase reported in anxiety disorders
Depression, Anxiety Up in Children, Teens Worldwide During Pandemic
Pooled prevalence estimates 25.2 and 20.5 percent for clinically elevated depression and anxiety symptoms, respectively
Anxiety-Related Adverse Event Clusters ID’d After Janssen Vaccine
Rate of syncope was 8.2 per 100,000 doses after Janssen COVID-19 vaccination versus 0.05 per 100,000 after flu shots
Lower Incomes Increase Cancer Worry, Anxiety During Pandemic
Worry, anxiety up with lower annual income for Medicaid-insured women receiving gynecologic oncology care during March 15 to April 15, 2020
Anxiety, Depressive Disorders Increased August 2020 to February 2021
In addition, increase seen in percentage of adults reporting they needed but did not receive mental health counseling or therapy
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
Patients With RA Have Increased Anxiety During Pandemic
Anxiety during pandemic correlated with Health Assessment Questionnaire, biologic drug use, and previous anxiety point
Anxiety, Depression Remain High Following Initial Lockdown
Depression more likely among men; anxiety more likely for women
Primary Care-Recorded Mental Illness Decreased During COVID-19
Reductions seen in incidence of primary care-recorded depression, anxiety disorders, first antidepressant prescribing in United Kingdom